Overview of the global tissue ablation market
According to the tissue ablation industry analysis, the global tissue ablation market is anticipated to grow at a steady rate and will post a CAGR of close to 10% during the forecast period. The increasing preference for minimally invasive (MI) procedures will drive the growth prospects for the global tissue ablation market until the end of 2021. The market is witnessing an increasing rate of adoption of tissue ablation devices in various medical facilities due to the numerous advantages associated with minimally invasive procedure procedures and this factor is increasing the tissue ablation market revenue. Some of these advantages are reduced the risk of infection, minimal complications, shorter hospital stay, less pain, and faster recovery time compared to traditional open surgeries. Also, several device manufacturers are increasingly conducting training programs for medical professionals on the use of tissue ablation devices to fuel the adoption rate of these devices.
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors contributing to growth in the market include the increasing older adult population, rise in a number of chronic diseases, and an increase in MI procedures.
Competitive landscape and key vendors
The global tissue ablation market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly focusing on conducting evidence-based studies to showcase the performance, efficacy, and long-term cost-effectiveness of their products.
Key vendors in this market are
- Boston Scientific
- Johnson & Johnson
- Medtronic
- St. Jude Medical
Other prominent vendors in the market include Abbott Laboratories, Accuray, Acoustic Medsystems, Advanced Cardiac Therapeutics, Alcon, Alpinion Medical System, American Medical Systems, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, BSD Medical, C.R. Bard, C2 Therapeutics, CardioFocus, Chongqing Haifu Medical Technology, Conmed, CSA Medical, Cynosure, Cytyc, EDAP TMS, Elekta, Esaote, Galil Medical, Hologic, InSightec, Lumenis, Mermaid Medical, MicroPort Scientific, Microsulis Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Philips Healthcare, Plasma Surgical, PLC Medical Systems, Profound Medical, Shenzhen Huikang Medical Apparatus, Smith & Nephew, Sonacare Medical, Spectranetics, Stryker, Terumo Medical, Theraclion, Total Vein Systems, Varian Medical, Vimecon, and Vivant Medical.
Segmentation by technology and analysis of the tissue ablation market
- Radiofrequency ablation
- EBRT
- Ultrasound ablation
- Laser-based ablation
- Cryoablation Devices
- Microwaves ablation
- Hydrothermal ablation
The external beam radiation therapy (EBRT) accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major applications of EBRT is to destroy cancer cells in men having high-grade prostate cancer and cancer in the lymph gland of the pelvis. This factor will positively impact the tissue ablation market value.
Segmentation by application and analysis of the tissue ablation market
- Oncology
- Cardiology
- Gynecology
- Cosmetology
- Urology
- Opthalmology
Based on the tissue ablation market overview, the oncology segment accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. One of the major factors responsible for the market segment’s growth is the flexibility involved in performing invasive surgeries or non-invasive surgeries depending on the type of cancerous cells.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global tissue ablation market?
- What are the key market trends impacting the growth of the global tissue ablation market?
- What are the challenges to market growth?
- Who are the key vendors in the global tissue ablation market?
- What are the market opportunities and threats faced by the vendors in the global tissue ablation market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global tissue ablation market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Cost analysis
PART 07: Market segmentation by product
- Global capital equipment market
- Global ablation catheters market
- Global tissue ablation consumables market
PART 08: Market segmentation by technology
PART 09: Market segmentation by application
PART 10: Market segmentation by end-user
- ASCs
- Hospitals
- Physicians' offices
PART 11: Geographical segmentation
- Tissue ablation market in the Americas
- Market size and forecast
- Tissue ablation market in EMEA
- Market size and forecast
- Tissue ablation market in APAC
- Market size and forecast
PART 12: Market drivers
- Rise in incidence of chronic diseases and older adult population
- Increase in MI procedures
- Advances in technology
- Growing use of medical lasers for oncology procedures
- Increase in disposable income
PART 13: Impact of drivers
PART 14: Market challenges
- Complications associated with energy and laser-based ablation devices
- Stringent regulatory approval processes
- High cost of surgeries
- Inadequate skilled practitioners
PART 15: Impact of drivers and challenges
PART 16: Market trends
- Use of robotic navigation technologies
- Focus on emerging countries
- Focus on R&D
- Rise in accessibility to advanced laser treatments
PART 17: Vendor landscape
PART 18: Key vendor analysis
- Boston Scientific
- Johnson & Johnson
- Medtronic
- St. Jude Medical
- Other prominent vendors
PART 19: Appendix
PART 20: Explore Technavio